LOGIN
Dexamethasone-Enhanced Adductor Canal Block for Persistent Pain After ACL Reconstruction
June 2025
Dexamethasone-Enhanced Adductor Canal Block for Persistent Pain After ACL Reconstruction
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Dexamethasone as an additive to bupivacaine in an ultrasound-guided adductor canal block for the management of persistent pain after arthroscopic reconstruction of the anterior cruciate ligament: a randomized, double-blind study.
BMC Anesthesiol . 2025 Apr 24;25(1):208.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Ninety patients undergoing arthroscopic ACL reconstruction were randomized to receive either a 20 ml mixture of 0.25% bupivacaine plus 8 mg dexamethasone (n=45) or 20 ml of 0.25% bupivacaine with saline (n=45) via ultrasound-guided adductor canal block. The primary outcome was the dynamic visual analog score (DVAS) at 1 month. Secondary outcomes included postoperative VAS scores at 24 hours, DVAS ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.